Groups opposed to the dam, including environmentalists and leaders of indigenous communities that stand to be affected if Belo Monte is built, vow to continue legal efforts to block the 11 billion ...

Belo Monte diverts a 100km stretch of the Xingu’s “Volta Grande,” or Big Bend, in the northern county of Altamira to power a hydroelectric dam with a capacity of 11,233 megawatts ...

Indigenous Peoples are putting their bodies on the line and it's our responsibility to make sure you know why. That takes time, expertise and resources - and we're up against a constant tide of ...

A Brazilian court on Thursday cleared mining giants BHP and Vale, and their Brazilian joint venture Samarco, of ...

Monte Rosa Therapeutics Inc (NASDAQ:GLUE) stock is trading higher on Monday after the company announced a global exclusive development and commercialization license agreement with Novartis AG ...

After years of controversy and construction, British Columbia’s Site C dam has begun generating power. BC Hydro said Monday that the first of six generating units at the hydroelectric dam on the ...

After a recent dam disaster, Nigerian officials blamed God, climate change and poor people. But experts had warned the dam was at risk well before it collapsed. The officials did nothing.

BOSTON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines ...

The Department of Water and Sanitation’s latest weekly report revealed a significant decline in the country’s dam water capacity levels. 31 dams nationally recorded levels of under 50% of ...

Oct 28 (Reuters) - Swiss pharmaceutical giant Novartis (NOVN.S), opens new tab will pay Monte Rosa Therapeutics (GLUE.O), opens new tab $150 million upfront payment for a global license to develop ...

Além do resgate de novelas clássicas, a plataforma estreia documentários imperdíveis, como o cantor Belo, o novo talk show de Angélica, filme nacional exclusivo, e a terceira temporada da ...

Don’t stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using ...